公司資料
Connect Biopharma Holdings Limited 股價、新聞與催化劑
- 股票代碼:
- CNTB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- China and listed in the U
股票表現
2.49 USD (-2.35%)
收盤價
最後更新: 2026年8月17日
135M USD
市值
股價為何變動
As of Aug 17, 2026, CNTB closed down 2.35% at $2.49. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Connect Biopharma is an immunology company focused on inflammatory and autoimmune diseases. Its story is built around developing targeted therapies for chronic immune-mediated conditions.
所在地與產業分類
Connect Biopharma is headquartered in China and listed in the U.S. market. It sits in specialty immunology biotechnology.
商業模式特徵
The company depends on clinical data, translational confidence, and the ability to progress a focused inflammatory pipeline. Investors watch efficacy signals and strategic developments.
生技產業定位
Connect occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs evidence that the platform can differentiate in a crowded area.
未來催化劑
- Connect Biopharma’s catalysts are its inflammatory-disease programs, especially any update that clarifies whether the company can still build a credible immunology story. The market will care about human data.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。